- Home
- AXSM vs COKE Comparison
AXSM vs COKE Comparison
Compare AXSM & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | COKE |
|---|---|---|
| Founded | 2012 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 10.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | AXSM | COKE |
|---|---|---|
| Price | $167.21 | $149.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 20 | 0 |
| Target Price | ★ $183.10 | N/A |
| AVG Volume (30 Days) | ★ 690.1K | 603.9K |
| Earning Date | 02-17-2026 | 02-19-2026 |
| Dividend Yield | N/A | ★ 0.68% |
| EPS Growth | N/A | ★ 22.14 |
| EPS | N/A | ★ 7.03 |
| Revenue | $561,263,000.00 | ★ $7,070,308,000.00 |
| Revenue This Year | $66.40 | N/A |
| Revenue Next Year | $56.13 | N/A |
| P/E Ratio | ★ N/A | $20.91 |
| Revenue Growth | ★ 65.83 | 4.22 |
| 52 Week Low | $79.19 | $105.21 |
| 52 Week High | $184.40 | $169.49 |
Technical Indicators
Market Signals| Indicator | AXSM | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 59.91 | 38.78 |
| Support Level | $168.58 | $142.83 |
| Resistance Level | $184.40 | $156.00 |
| Average True Range (ATR) | 6.66 | 3.73 |
| MACD | 1.25 | -2.12 |
| Stochastic Oscillator | 54.99 | 26.65 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.